Literature DB >> 15305365

Anatomical and cellular localization of neuroactive 5 alpha/3 alpha-reduced steroid-synthesizing enzymes in the spinal cord.

Christine Patte-Mensah1, Trevor M Penning, Ayikoe G Mensah-Nyagan.   

Abstract

The complementary activities of 5 alpha-reductase (5 alpha-R) and 3 alpha-hydroxysteroid dehydrogenase (3 alpha-HSD) are crucial for the synthesis of neuroactive 5 alpha/3 alpha-reduced steroids, such as 3 alpha-androstanediol, allopregnanolone, and tetrahydrodeoxycorticosterone, which control several important neurophysiological mechanisms through allosteric modulation of gamma-aminobutyric acid type A receptors. Immunocytochemical localization of 3 alpha-HSD in the central nervous system (CNS) has never been determined. The presence and activity of 5 alpha-R have been investigated in the CNS, but only the brain was considered; the spinal cord (SC) received little attention, although this structure is crucial for many sensorimotor activities. We have determined the first cellular distribution of 5 alpha-reductase type 1 (5 alpha-R1) and type 2 (5 alpha-R2) and 3 alpha-HSD immunoreactivities in adult rat SC. 5 alpha-R1 immunostaining was detected mainly in the white matter (Wm). In contrast, intense 5 alpha-R2 labeling was observed in dorsal (DH) and ventral horns of gray matter (Gm). 3 alpha-HSD immunoreactivity was largely distributed in the Wm and Gm, but the highest density was found in sensory areas of the DH. Double-labeling experiments combined with confocal analysis revealed that, in the Wm, 5 alpha-R1 was localized in glial cells, whereas 35% of 5 alpha-R2 and 3 alpha-HSD immunoreactivities were found in neurons. In the DH, 60% of 5 alpha-R2 immunostaining colocalized with oligodendrocyte, 25% with neuron, and 15% with astrocyte markers. Similarly, 45% of 3 alpha-HSD immunoreactivity was found in oligodendrocytes, 35% in neurons, and 20% in astrocytes. These results are the first demonstrating that oligodendrocytes and neurons of the SC possess the key enzymatic complex for synthesizing potent neuroactive steroids that may control spinal sensorimotor processes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15305365     DOI: 10.1002/cne.20251

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  22 in total

Review 1.  Fast nongenomic effects of steroids on synaptic transmission and role of endogenous neurosteroids in spinal pain pathways.

Authors:  Rémy Schlichter; Anne Florence Keller; Mathias De Roo; Jean-Didier Breton; Perrine Inquimbert; Pierrick Poisbeau
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

Review 2.  Neurogenic pain and steroid synthesis in the spinal cord.

Authors:  Christine Patte-Mensah; Cherkaouia Kibaly; Domitille Boudard; Véronique Schaeffer; Aurélie Béglé; Simona Saredi; Laurence Meyer; Ayikoe G Mensah-Nyagan
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

3.  Cellular and functional evidence for a protective action of neurosteroids against vincristine chemotherapy-induced painful neuropathy.

Authors:  Laurence Meyer; Christine Patte-Mensah; Omar Taleb; Ayikoe Guy Mensah-Nyagan
Journal:  Cell Mol Life Sci       Date:  2010-04-30       Impact factor: 9.261

4.  Regional distribution of 5α-reductase type 2 in the adult rat brain: an immunohistochemical analysis.

Authors:  M Paola Castelli; Alberto Casti; Angelo Casu; Roberto Frau; Marco Bortolato; Saturnino Spiga; Maria Grazia Ennas
Journal:  Psychoneuroendocrinology       Date:  2012-07-08       Impact factor: 4.905

5.  Substance P inhibits progesterone conversion to neuroactive metabolites in spinal sensory circuit: a potential component of nociception.

Authors:  Christine Patte-Mensah; Cherkaouia Kibaly; Ayikoe G Mensah-Nyagan
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-10       Impact factor: 11.205

6.  The progesterone derivative dydrogesterone down-regulates neurokinin 1 receptor expression on lymphocytes, induces a Th2 skew and exerts hypoalgesic effects in mice.

Authors:  Arif Suphi Orsal; Sandra Blois; Dominika Labuz; Eva M J Peters; Martin Schaefer; Petra C Arck
Journal:  J Mol Med (Berl)       Date:  2005-12-31       Impact factor: 4.599

7.  Estrogen signaling is necessary for exercise-mediated enhancement of motoneuron participation in axon regeneration after peripheral nerve injury in mice.

Authors:  Melina C Acosta; Patricia A Copley; Jamie R Harrell; Jennifer C Wilhelm
Journal:  Dev Neurobiol       Date:  2017-04-21       Impact factor: 3.964

8.  Progesterone effects on neuronal ultrastructure and expression of microtubule-associated protein 2 (MAP2) in rats with acute spinal cord injury.

Authors:  Susana L González; Juan José López-Costa; Florencia Labombarda; Maria Claudia González Deniselle; Rachida Guennoun; Michael Schumacher; Alejandro F De Nicola
Journal:  Cell Mol Neurobiol       Date:  2008-06-27       Impact factor: 5.046

9.  Beneficial effects of Gelsemium-based treatment against paclitaxel-induced painful symptoms.

Authors:  Ludivine Vitet; Christine Patte-Mensah; Naoual Boujedaini; Ayikoé-Guy Mensah-Nyagan; Laurence Meyer
Journal:  Neurol Sci       Date:  2018-09-24       Impact factor: 3.307

Review 10.  Endogenous and synthetic neurosteroids in treatment of Niemann-Pick Type C disease.

Authors:  Synthia H Mellon; Wenhui Gong; Marcus D Schonemann
Journal:  Brain Res Rev       Date:  2007-06-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.